Skip to content
OpenCapital
Get started

Rigel Pharmaceuticals RIGL Investment Income Net Amortization Of Discount And Premium

Investment Income Net Amortization Of Discount And Premium at other companies

TG Therapeutics logo
TG TherapeuticsTGTX
$367K-72.5%

Other financials

Income statement

See full
Revenue$58.8M+10.3%
Gross profit$54.2M+10.8%
Operating income$11.9M-7.0%
Net income$8.7M-24.4%
EPS (diluted)$0.44-30.2%

Balance sheet

See full
Cash & equivalents$24.5M-46.6%
Total debt$68.4M+5,079%
Total equity$399.9M+2,054%
Total assets$504.6M+187%

Cash flow

See full
Operating cash flow$2.7M+405%
CapEx$73.0K—
Free cash flow-$22.0M—

Valuation

See full
Market cap$684.39M+102%
Enterprise value$728.29M+148%
P/E1.9×-7.2×
P/S2.3×+0.6×

Profitability

See full
Gross margin93.4%+3.7pp
Operating margin41.6%+19.9pp
Net margin121.5%+103pp
FCF margin-61.7%—

Returns & leverage

See full
Return on equity174.1%—
Debt / equity0.2×+0.1×
Current ratio2.6×+0.4×

Where this comes from

Reported directly by Rigel Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium.

The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rigel Pharmaceuticals's investment income net amortization of discount and premium.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rigel Pharmaceuticals's investment income net amortization of discount and premium?
Rigel Pharmaceuticals (RIGL) reported investment income net amortization of discount and premium of $170K in Q1 2026.
How has Rigel Pharmaceuticals's investment income net amortization of discount and premium changed year-over-year?
Rigel Pharmaceuticals's investment income net amortization of discount and premium decreased by 10.5% year-over-year, from $190K to $170K.
What is the long-term trend for Rigel Pharmaceuticals's investment income net amortization of discount and premium?
Over 4 years (2021 to 2025), Rigel Pharmaceuticals's investment income net amortization of discount and premium has grown at a 41.5% compound annual growth rate (CAGR), from -$287K to $1.15M.
What does investment income net amortization of discount and premium mean?
Reflects the net non-cash adjustment to operating cash flow related to the amortization of premiums or discounts on investment securities. This adjustment reconciles the interest income recognized in net income with the actual cash received from investments. It helps investors understand the underlying yield and valuation adjustments of the company's liquid asset portfolio.